Bismuth Subnitrate Research Articles

Untargeted metabolomics and metagenomics reveal signatures for intramammary ceftiofur treatment and lactation stage in the cattle hindgut.

The gut microbiota in cattle is essential for protein, energy, and vitamin production and hence, microbiota perturbations can affect cattle performance. This study evaluated the effect of intramammary (IMM) ceftiofur treatment and lactation stage on the functional gut microbiome and metabolome. Forty dairy cows were enrolled at dry-off. Half received IMM ceftiofur and a non-antibiotic teat sealant containing bismuth subnitrate (cases), while the other half received the teat sealant (controls). Fecal samples were collected before treatment at dry off, during the dry period (weeks 1 and 5) and the first week after calving (week 9). Shotgun metagenomic sequencing was applied to predict microbial metabolic pathways whereas untargeted metabolomics was used identify polar and nonpolar metabolites. Compared to controls, long-term changes were observed in the cows given ceftiofur, including a lower abundance of microbial pathways linked to energy production, amino acid biosynthesis, and other vital molecules. The metabolome of treated cows had elevated levels of stachyose, phosphatidylethanolamine diacylglycerol (PE-DAG), and inosine a week after the IMM ceftiofur application, indicating alterations in microbial fermentation, lipid metabolism, energy, and cellular signaling. Differences were also observed by sampling, with cows in late lactation having more diverse metabolic pathways and a unique metabolome containing higher levels of histamine and histamine-producing bacteria. These data illustrate how IMM ceftiofur treatment can alter the functionality of the hindgut metabolome and microbiome. Understanding how antibiotics and lactation stages, which are each characterized by unique diets and physiology, impact the function of resident microbes is critical to define normal gut function in dairy cattle.

Different routes of bismuth mineral transformation during pertechnetate and perrhenate uptake for subsurface remediation

Removal of pertechnetate 99TcO4− and perrhenate ReO4− during mineral transformation of the non-toxic basic bismuth subnitrate for subsurface remediation.

Evaluation of internal teat sealant persistence in the mammary gland during the dry period

The aim of this study was to characterize the behavior of 2 commercially available internal teat sealants containing bismuth subnitrate (SOa and ORBb) during the dry- and postfresh periods in dairy cattle. Digital radiography was used to monitor location and percentage of teat cistern fill at dry-off and during the dry period. Teat-level health parameters including infection status at dry-off and post-fresh as well as incidence of clinical mastitis were also assessed. Radiographic imaging revealed that 21.1% of teats had sealant present in the gland cistern at dry-off (SO= 23.6%, ORB = 18.5%) which increased to 55.9% (SO = 59.6%, ORB = 52.2%) at pre-fresh imaging. Quarters with sealant that had migrated into the gland shed noticeable amounts of sealant for twice as long (mean 14.34 milkings), compared to quarters that did not have sealant in the gland (mean: 7.12, P < 0.001). There was no correlation between sealant location and intramammary infection at dry-off or post-fresh, nor did sea ant location impact clinical mastitis in the first 120 days in milk. Milk leakage after dry-off also was not correlated with an increased risk of intramammary infection during the dry or post-fresh periods. There was no difference between treatments in any of the parameters evaluated. Prolonged sealant shedding is a common reason that producers cite for not utilizing internal teat sealant products in their dry-off protocols. Further research is indicated to determine the optimal amount of sealant required to provide protection while minimizing post-fresh shedding.

Randomized equivalence study evaluating the efficacy of two commercially available teat sealants in dairy cows

Use of internal teat sealants is common in the U.S. to prevent new intramammary infections during the dry period. The objective of this study was to compare the efficacy of a new internal teat sealant containing bismuth subnitrate (SOa) to the first product introduced to the U.S. dairy industry (ORBb). The hypothesis was completed using a multi-site randomized, positively controlled equivalence evaluation of new intramammary infection risk difference over the dry period. At dry-off, milk samples were collected for culture and then cloxacillin benzathinec was administered, followed by the randomly assigned internal teat sealant (SO = 404 cows; ORB = 418 cows). After calving, repeat milk samples were collected. The effect of treatment on quarter-level new intramammary infection risk, cured intramammary infection risk, and risk of presence of intramammary infection post-calving was determined using generalized linear mixed models. The effects of treatment on cow-level outcomes, including incidence of clinical mastitis, culling and death, and performance in early lactation based on test-day milk production and somatic cell count, were also evaluated. The dry period new intramammary infection adjusted risk difference (SO minus ORB) was -1.60% (95% CI -5.62, 2.42). Final models demonstrated that there was no difference in risk rates of quarter-level outcomes between treatment groups. Analysis of cow-level factors, including clinical mastitis, culling and death rate within the first 120 DIM, also revealed no differences. Results of this study indicate that SO was equivalent to ORB for dry period new intramammary infection risk when utilizing blanket dry cow therapy.

Persistent effects of intramammary ceftiofur treatment on the gut microbiome and antibiotic resistance in dairy cattle

BackgroundIntramammary (IMM) ceftiofur treatment is commonly used in dairy farms to prevent mastitis, though its impact on the cattle gut microbiome and selection of antibiotic-resistant bacteria has not been elucidated. Herein, we enrolled 40 dairy (Holstein) cows at the end of the lactation phase for dry-cow therapy: 20 were treated with IMM ceftiofur (Spectramast®DC) and a non-antibiotic internal teat sealant (bismuth subnitrate) and 20 (controls) received only bismuth subnitrate. Fecal grab samples were collected before and after treatment (weeks 1, 2, 3, 5, 7, and 9) for bacterial quantification and metagenomic next-generation sequencing.ResultsOverall, 90% and 24% of the 278 samples had Gram-negative bacteria with resistance to ampicillin and ceftiofur, respectively. Most of the cows treated with ceftiofur did not have an increase in the number of resistant bacteria; however, a subset (25%) shed higher levels of ceftiofur-resistant bacteria for up to 2 weeks post-treatment. At week 5, the antibiotic-treated cows had lower microbiota abundance and richness, whereas a greater abundance of genes encoding extended-spectrum β-lactamases (ESBLs), CfxA, ACI-1, and CMY, was observed at weeks 1, 5 and 9. Moreover, the contig and network analyses detected associations between β-lactam resistance genes and phages, mobile genetic elements, and specific genera. Commensal bacterial populations belonging to Bacteroidetes most commonly possessed ESBL genes followed by members of Enterobacteriaceae.ConclusionThis study highlights variable, persistent effects of IMM ceftiofur treatment on the gut microbiome and resistome in dairy cattle. Antibiotic-treated cattle had an increased abundance of specific taxa and genes encoding ESBL production that persisted for 9 weeks. Fecal shedding of ESBL-producing Enterobacteriaceae, which was classified as a serious public health threat, varied across animals. Together, these findings highlight the need for additional studies aimed at identifying factors associated with shedding levels and the dissemination and persistence of antibiotic resistance determinants on dairy farms across geographic locations.

Randomized, noninferiority trial evaluating the efficacy of a novel teat sealant in pasture grazed dairy cows

The intramammary infusion at the end of lactation of a bismuth subnitrate internal teat sealant (ITS), with no antibiotic component has been shown to be an effective means of reducing new intramammary infections over the dry period. There has, however, been very few comparative studies between different brands of ITS under grazed pasture conditions. The objectives of this study were, therefore, to determine if a new bismuth subnitrate internal teal sealant (ShutOut, MSD Animal Health) was noninferior to Teatseal (Zoetis) regarding end-points such as (a) detection of the ITS product after calving, (b) clinical mastitis during the dry period and early lactation, and (c) subclinical mastitis at 30 to 60 d in milk. A total of 1,105 mixed-age cattle were enrolled across 2 farms comparing 2 ITS products for detection of the ITS at calving and prevention of clinical and subclinical mastitis. Both ITS contained 65% (2.6 g) bismuth salts emulsified in ≤ 1.4 g of mineral oil (ShutOut as investigational product, IVP; Teatseal as control product, CPT). At dry-off, treatment was allocated to every second cow. All cows met industry best practice criteria for using ITS treatment without antibiotics. Outcomes included detection of ITS at first stripping of the udder by the farmer, clinical mastitis (CM) from dry-off to 30 d following calving and subclinical mastitis at 30 to 60 d following calving. For ITS detection, a generalized mixed linear regression model was used to model the data, with clustering of quarters within cow accounted for by including cow as a random intercept. Clinical mastitis was analyzed at the cow-level using a Fisher's exact test, and SCC was modeled using a negative binomial distribution. The IVP was noninferior to the CPT for ITS detection following calving. There were 1344/1800 (71.5%) of quarters with ITS detection in the IVP in comparison to 1076/1604 (67.1%) of quarters in the CPT treated group. The quarter-level CM incidence risk was low (45 cases out 4,324 quarters; 1.04%). The overall cow-level CM risk was 4.1% (44/1081), with 20/540 (3.7%) cases in animals in the IVP group and 24/541 (4.4%) cases in animals in the CPT group. The IVP was noninferior to the CPT for cow-level mastitis incidence. The median SCC for all animals was 23,000 cells/mL, with a mean of 92,000 cells/mL. The back-transformed estimated marginal mean estimated SCC was 84,800 (95% CI 75,200-95,600) cells/mL for animals in the IVP group, and 98,800 (95% CI 87,600-111,300) cells/mL for animals in the CPT group. The IVP was, therefore, noninferior for all outcomes measured.

Fabrication of novel BiVO4/Bi2O3 heterostructure with superior visible light induced photocatalytic properties

Heterostructure BiVO4/Bi2O3 nanocomposites with enhanced visible light activity are effectively synthesized through an easiest and single step hydrothermal route, using bismuth subnitrate and ammonium meta-vanadate as main raw materials in existence of citric acid. The phase and surface structure, topography and optical properties of synthesized composites are characterized by XRD, SEM, EDX, FTIR, UV–Visible and PL spectroscopy. It was found that 5%BiVO4/Bi2O3 (BOBV-5) nanocomposite exhibit excellent photocatalytic performance for rhodamine B dye degradation and tetracyclic under irradiation of visible light as compared to single component i.e. BiVO4. The increased photocatalytic activity should be ascribed for making p–n heterojunction among p-type Bi2O3 and n-type BiVO4. This p–n heterojunction successfully reduce the recombination of photogenerated charge carriers. Furthermore, the BOBV-5 novel photocatalyst shows good stability in constructive five cycles and photocatalytic activity is best for conquering photo corrosion of a photocatalysts. To explain charge migration route, whole photocatalytic mechanism was described in terms of energy band structures. Furthermore, the present work is helpful effort for design of new visible light photocatalytic materials with heterojunction structures.

Influence of SERS effect on surface-active popcorns as nanotheranostics against H. pylori-induced peptic ulcer

Current treatment strategies for peptic ulcers caused by Helicobacter pylori includes quadruple therapy with limited effectiveness. The work focused on surface modulation of metallic nanopopcorns for adsorption of bismuth subnitrate to detect and kill H. pylori by the influence of Surface Enhanced Raman Spectroscopic (SERS), a surface-sensitive method is used for theranostics application. Nanopopcorns prepared by Terkevich method and characterized for morphology, adsorption, spectroscopic and in-vitro drug release studies. Adsorption efficiency of the nanopopcorns for bismuth subnitrate was 79.9%. In-vitro release studies showed initial burst release, followed by controlled release for 24 h. SERS analysed the nanopopcorn's activity on the bacteria and their subsequent cell death pattern. Novel drug delivery system with large surface area offers effective strategies for diagnosis and treatment in various diseases.

New drugs for horses and production animals in 2021

In 2021, one novel pharmaceutical agent for horses or food-producing animals was released on the German market, making the anti-haemorrhagic etamsylate (Hemosilate) available for horses, cattle, pigs, sheep, goats, dogs and cats, for the first time. The authorization of one established veterinary active ingredient was extended to an additional species: The endectocide eprinomectin (Eprecis®) from the group of macrocyclic lactones was also approved for sheeps and goats. Additionally, two veterinary formulations with a new active substance content (bromhexine, tiamulin) and one active ingredient in a novel pharmaceutical formulation (indigo carmine stained intramammary suspension with heavy bismuth subnitrate) appeared on the market. Furthermore, one active ingredient (oxytetracycline) is again available for horses on the market for horses and food-producing animals.

The effectiveness of an internal teat sealant in preventing new intra mammary infections in dairy cattle during dry period

The aim of our study was to evaluate the effect of an internal teat sealant infused upon drying off on the incidence of new intra-mammary infections (IMI) during the dry period in dairy cattle. Due to the non-availability of the product on the Indian market, the product was prepared in a laboratory using bismuth subnitrate and liquid paraffin. A total of 64 quarters free from infection on culture were selected for the study at 60 days before the expected date of parturition. The quarters were randomly divided into two groups (group A and group B), with 32 quarters in each group. The group A quarters were infused with teat sealant at the time of drying off, and the quarters in group B were kept as the control and no treatment was provided to them. Milk samples from all the selected quarters were subjected to cultural examination at the time of drying off and 1-3 days post calving. The incidence of new IMI’s between drying off and calving was significantly lower for group A quarters when compared to group B quarters (12.5% vs 34.4%). The incidence of new IMI’s in group A and group B quarters was significantly lower for Streptococcus uberis (3.13% vs 18.75%) and Streptococcus dysgalactiae (3.13% vs 12.5%). The study concluded that infusion of teat sealant at drying off is helpful in lowering the incidence of new IMI’s during the dry period.

Multiferroic bismuth ferrite nanomagnets as potential candidates for spintronics at room temperature

Bismuth ferrite nanoparticle (BFO) is found to be a major contributor in the field of piezoelectricity, spintronics, and ferroelectric memory devices. BFO is synthesized using a 1:1 stoichiometric ratio of bismuth subnitrate and Iron(III) nitrate nonahydrate at relatively low temperature by cost-effective sol-gel method. The morphology and chemical composition of nanopowders were studied using Field Emission Scanning Electron Microscope (FESEM) and EDX. The phase and crystallinity were determined using X-ray diffractometer with CuKα radiation (λ = 1.54 Å). Investigation of magnetic properties was carried out at room temperature using Vibrating Sample Magnetometer (VSM) by applying maximum magnetic field up to ± 30 kOe. The BFO exhibited rhombohedral distorted perovskite structure at room temperature. The room temperature hysteresis loop displayed the weak ferromagnetism of BFO, which makes it a potential candidate in the area of spintronics.

Electrodes for Paracetamol Sensing Modified with Bismuth Oxide and Oxynitrate Heterostructures: An Experimental and Computational Study

In this work, novel platforms for paracetamol sensing were developed by the deposition of Bi2O3, Bi5O7NO3 and their heterostructures onto screen-printed carbon-paste electrodes. An easy and scalable solid state synthesis route was employed, and by setting the calcination temperatures at 500 °C and 525 °C we induced the formation of heterostructures of Bi2O3 and Bi5O7NO3. Cyclic voltammetry measurements highlighted that the heterostructure produced at 500 °C provided a significant enhancement in performance compared to the monophases of Bi2O and Bi5O7NO3, respectively. That heterostructure showed a mean peak-to-peak separation Ep of 411 mV and a sensitivity increment of up to 70% compared to bare electrodes. A computational study was also performed in order to evaluate the geometrical and kinetic parameters of representative clusters of bismuth oxide and subnitrate when they interact with paracetamol.

Bismuth Subnitrate-Catalyzed Markovnikov-Type Alkyne Hydrations under Batch and Continuous Flow Conditions.

Bismuth subnitrate is reported herein as a simple and efficient catalyst for the atom-economical synthesis of methyl ketones via Markovnikov-type alkyne hydration. Besides an effective batch process under reasonably mild conditions, a chemically intensified continuous flow protocol was also developed in a packed-bed system. The applicability of the methodologies was demonstrated through hydration of a diverse set of terminal acetylenes. By simply switching the reaction medium from methanol to methanol-d4, valuable trideuteromethyl ketones were also prepared. Due to the ready availability and nontoxicity of the heterogeneous catalyst, which eliminated the need for any special additives and/or harmful reagents, the presented processes display significant advances in terms of practicality and sustainability.

Internal Teat Sealant Administered at Drying off Reduces Intramammary Infections during the Dry and Early Lactation Periods of Dairy Cows.

Simple SummaryInternal teat sealant (ITS) at drying off is a strategy used for the prevention of intramammary infections (IMI) during the dry period (DP), as it simulates the keratin plug’s purpose, which is to prevent the access of pathogens into the mammary gland. The results from randomized clinical trials provide valuable information about the efficacy of commercially available products to be used in dairy cattle, assisting farmers to choose the best protocols for mastitis control. This study evaluated a new ITS infused at drying off as an alternative to prevent IMI during DP in a tropical country. Our results showed no effect of treatments on risk of bacteriological cure, subclinical mastitis (SCM) cure, and new cases of SCM postpartum. On the other hand, the use of ITS combined with an intramammary antibiotic (SDCT) reduced the risk of clinical mastitis up to 60 days postpartum, the overall risk of new intramammary infections (NIMI), and the NIMI caused by major pathogens compared to the use of antimicrobial alone (ADCT). Thus, the use of ITS combined with an antimicrobial at drying off was effective to prevent NIMI and clinical mastitis up to 60 days postpartum.The effect of an internal teat sealant (ITS) on subsequent infection of the mammary gland was evaluated on the following mammary gland health indicators: (a) bacteriological cure of preexisting intramammary infections at drying off, (b) risk of postpartum new intramammary infections (NIMI), (c) cure and risk of new cases of subclinical mastitis (SCM), and (d) risk of postpartum clinical mastitis (CM). A total of 553 cows during late gestation were randomly assigned into two treatment protocols at drying off: (a) Dry cow therapy with 0.25 g of intramammary anhydrous cefalonium (ADCT; Cepravin®, MSD Animal Health); or (b) ADCT combined with ITS (SDCT; 4 g bismuth subnitrate; Masti-Seal®, MSD Animal Health, São Paulo, Brazil). Mammary quarter (MQ) milk samples were collected for microbiological culture and somatic cell count (SCC) at drying off and early lactation, and data from 1756 MQ were used in the multivariate logistic regression. There was no effect on the risk of bacteriological cure, SCM cure, and new cases of postpartum SCM. Still, SDCT reduced the risk of CM up to 60 days postpartum (DPP), overall NIMI risk, and the NIMI caused by major pathogens compared to ADCT. Thus, the DCT combined with ITS at drying off is effective for preventing NIMI during the dry period and CM up to 60 DPP.

Cellular Response of Neutrophils to Bismuth Subnitrate and Micronized Keratin Products In Vitro.

The aim of this study was to assess the effect of bismuth subnitrate and micronized keratin on bovine neutrophils in vitro. We hypothesized that recruitment and activation of neutrophils into the teat canal and sinus are the mechanisms of action of bismuth subnitrate and keratin-based teat sealant formulations. To test this, a chemotaxis assay (Experiment 1) and a myeloperoxidase (MPO) assay (Experiment 2) were conducted in vitro. Blood was sampled from 12 mid-lactation dairy cows of variable ages. Neutrophils were extracted and diluted to obtain cell suspensions of approximately 106 cells/mL. In Experiment 1, test substances were placed in a 96-well plate, separated from the cell suspension by a 3 µm pore membrane and incubated for 3 h to allow neutrophils to migrate through the membrane. In Experiment 2, neutrophils were exposed to the test products and the amount of MPO released was measured by optical density. Results showed that neutrophils were not activated by bismuth or keratin products (p < 0.05) in all of the tests performed. These results suggest that the mechanisms of action of bismuth subnitrate and keratin-based teat sealants do not rely on neutrophil recruitment and activation in the teat canal and sinus after treatment.

Comparative efficacy of dry cow therapy and internal teat sealant on intramammary infection during subsequent lactation

In the present study cows were screened 75th day before expected date of calving by using MCMT, somatic cell count and pH. Then positive cows for subclinical mastitis were randomly divided into four groups, each comprising of 8 cows. MCMT, SCC and pH evaluation were performed in milk samples of all the 32 cattle under therapy on day 0 pre-treatment (at drying off) and 7, 45 and 90 post treatment (after calving). The result revealed significant decrease in SCC and MCMT grading in all the treatment groups that reached towards normal after treatment. On the basis of MCMT grading and drastic reduction in SCC on 7th, 45th and 90th day post treatment in animals of group T3 (Ceftiofur hydrochloride and Internal Teat sealant) revealed highest recovery followed by T1 (Ceftiofur hydrochloride) and T2 (Teat sealant (Bismuth subnitrate) alone.

Spectrophotometric Determination of PEG in Waterlogged Archaeological Wood and Impregnation Solutions

ABSTRACT The aim of the present work was to test the applicability of the spectrophotometric method for the determination of polyethylene glycol (PEG) 4000 using bismuth subnitrate (BiONO3) to monitor the content of PEG in impregnated archaeological wood. Absorption spectra were collected in the visible light (VIS) range from 400 to 600 nm. The weight of the wood samples tested ranged from 50 to 120 mg. The PEG content was measured in aqueous extracts with the concentration of up to 30 mg·L−1. The results confirmed the high sensitivity and precision of the method used. The performed analyses were characterized by repeatability and selectivity towards PEG 4000 in a mixture containing PEG 300. The applicability of the PEG 2000 quantitative determination method was confirmed.

TLC-MS identification of alkaloids in Leonuri Herba and Leonuri Fructus aided by a newly developed universal derivatisation reagent optimised by the response surface method.

Dragendorff's reagent has low sensitivity and non-specificity for some alkaloids. A new alkaloid derivatisation reagent has been developed and optimised by using a Box-Behnken design method. This new reagent is applicable for structurally diverse natural alkaloids, and is proposed as a universal alkaloid staining reagent. To establish an efficient and sensitive thin-layer chromatography (TLC) identification method for Leonuri Herba and Leonuri Fructus to characterise their differences and similarities. Three key components (bismuth subnitrate, potassium iodide and iodine) in the derivatisation reaction were re-constructed and optimised using a response surface method. Different inorganic acids, essential additives of the staining reaction, were compared by a single-factor experiment design. This newly optimised reagent for alkaloids reported in this study, named the enhanced Dragendorff-Wagner's reagent, is composed of 0.82% bismuth subnitrate, 11.1% potassium iodide and 0.76% iodine in 38% phosphoric acid solution. Validation results indicate that the TLC spot of stachydrine stained with the enhanced Dragendorff-Wagner's reagent had a limit of detection of 2.0 μg, good intra- and inter-plate, and intra- and intra-day precisions with relative standard devition values less than 5.0%, and stability over 90 min. This enhanced Dragendorff-Wagner's reagent was applied for TLC identification of 16 reference alkaloids representing 11 structural skeletons, and two closely related herbs (Leonuri Herba and Leonuri Fructus). This newly enhanced Dragendorff-Wagner's reagent is a universal, effective, and sensitive staining reagent for alkaloids.

Effect of Bismuth Subnitrate Teat Canal Sealant with Ampicillin-Cloxacillin Combination in Control of Bovine Mastitis in Selected Farms in Kenya

This study presents the results of effect of a combination of bismuth subnitrate teat canal sealant (Boviseal® -Bimeda® Animal Health, Ireland) and the antibiotic Ampicillin &amp; Cloxacillin (Bovaclox® DC-Norbrook Laboratories Ltd-UK) when used during the dry period on occurrence of mastitis 100 days post-calving. The objectives of this study were: to determine the effect of Boviseal® teat canal sealant in combination with Bovaclox® DC in control of dairy cow mastitis 100 days after calving; to determine bacterial pathogens causing mastitis in the selected farms and to determine risk factors for occurrence of dairy mastitis in the selected farms. This controlled field trial was carried out in two Kenyan dairy farms: Chemusian Farm in Nakuru County and Gicheha Farm in Kiambu County. 156 dairy cows were used in the study. Healthy cows with no history of mastitis in their current lactation were recruited. They were randomly placed into either of the two study groups: the control and the test group. The Control group received Bovaclox® DC while the Test group received the Bovaclox® DC followed by Boviseal®. The cows were followed during the entire dry period and 100 days post-calving monitoring for mastitis occurrence. Cows in the control group were more susceptible to mastitis 100 days post-calving compared to cows in the treatment group (P&lt;0.001, RR=4.4, OR=17.7). Of the bacterial pathogens, coagulase negative Staphylococci (CNS) were the most common pathogens isolated from mastitic milk at 34.6 % followed by Micrococcus spp. (9.0%). Other bacteria isolated were Streptococcus agalactiae (3.8%), Staphylococcus aureus (1.9%); Escherichia coli (0.6%) and various bacterial mixtures. Results of logistic regressions at P≤0.05 showed that farm, position of the quarter, type of barn floor and type of treatment were significantly associated with occurrence of mastitis. Cows in Gicheha farm whose barn floor was earthen, those cows in the control group and hindquarters were risk factors for mastitis (RR=1.5, 4.4 and 1.18 respectively). The results of this study showed that Bovaclox® DC + Boviseal® teat canal sealant combination applied during the dry period is more effective in controlling bovine mastitis 100 days post-calving compared to the use of Bovaclox® DC alone. The study thus recommends the use of Bovaclox® DC + Boviseal® dry cow combination for control of bovine mastitis.

Effect of bismuth subnitrate on in vitro growth of major mastitis pathogens

The mode of action of bismuth subnitrate in teat sealant formulations as a preventative for intramammary infections during the dry period is unknown. Although previous studies proposed an action mechanism-creating a physical barrier in the teat canal to prevent bacterial invasion-it has not been proven experimentally. We hypothesized that bismuth subnitrate has an inhibitory effect on bacterial growth, in addition to its barrier effect. The objective of this study was to assess the effect of bismuth subnitrate on bacterial growth of major mastitis-causing agents. A strain of Streptococcus uberis (SR115), 2 strains of Staphylococcus aureus (SA3971/59 and SA1), and a strain of Escherichia coli (P17.14291) were tested in vitro for their ability to grow in the presence or absence of bismuth subnitrate. Disk diffusion testing, impedance measurement, and evaluation of bacterial growth in shaking conditions were the methods used to test this hypothesis. A reduction of growth in the presence of bismuth subnitrate occurred for all the strains tested. However, we observed strain and species variations in the extent of growth inhibition. These results suggest that an inhibitory effect on bacterial growth by bismuth subnitrate could partially explain the efficacy of bismuth-based formulations for preventing intramammary infections over the dry period. Further research is required to test the effect of teat sealant formulations on bacterial growth.